---
document_datetime: 2023-09-21 19:10:36
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/bonviva-epar-all-authorised-presentations_en.pdf
document_name: bonviva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0403512
conversion_datetime: 2025-12-29 21:53:28.570626
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of Administration   | Packaging                  | Content        | Package size          |
|-----------------|-----------------|------------|------------------------|---------------------------|----------------------------|----------------|-----------------------|
| EU/1/03/265/003 | Bonviva         | 150 mg     | Film-coated tablet     | Oral use                  | Blister (PVC/PVDC)         |                | 1 tablet              |
| EU/1/03/265/004 | Bonviva         | 150 mg     | Film-coated tablet     | Oral use                  | Blister (PVC/PVDC)         |                | 3 tablets             |
| EU/1/03/265/005 | Bonviva         | 3 mg       | Solution for injection | Intravenous               | Pre-filled syringe (glass) | 3 ml (1 mg/ml) | 1 pre-filled syringe  |
| EU/1/03/265/006 | Bonviva         | 3 mg       | Solution for injection | Intravenous               | Pre-filled syringe (glass) | 3 ml (1 mg/ml) | 4 pre-filled syringes |